PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
July 20, 2023 09:07 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, July 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
July 14, 2023 07:55 ET
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Joshin Delivers Pioneering Inclusive Support Program to Tyson Foods
June 28, 2023 09:00 ET
|
Joshin
MINNEAPOLIS, June 28, 2023 (GLOBE NEWSWIRE) -- Joshin, a company that provides comprehensive solutions for disability and neurodivergence support in the workplace, today announced it is expanding...
PaxMedica CEO Interviewed by The BRAIN Foundation
June 20, 2023 08:30 ET
|
PaxMedica, Inc.
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on...
PaxMedica Completes HAT-301 Registrational Trial for PAX-101
June 01, 2023 08:00 ET
|
PaxMedica, Inc.
HAT-301 is the Pivotal Efficacy Study to Support Upcoming NDA Filing Top Line Results Planned for Release in July 2023 TARRYTOWN, NY, June 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...
Specialized Education Services, Inc. Grows Educational Offerings in Illinois With Acquisition of NewHope Academy
May 11, 2023 11:42 ET
|
Specialized Education Services, Inc.
PHILADELPHIA, May 11, 2023 (GLOBE NEWSWIRE) -- Specialized Education Services, Inc. (SESI) today announced the acquisition of NewHope Academy (NHA), a special education school in Arlington Heights,...
CentralReach’s Special Education Solution, LiftEd, and EMR Solution for Small Practices, CR Essentials, Honored as Winners of the 2023 American Business Awards®
April 28, 2023 11:00 ET
|
CentralReach
FORT LAUDERDALE, Fla., April 28, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD care software, has been named a winner in two categories of the 21st Annual American...
Film, Art and Life Blends Together in “The Midway Point”
April 18, 2023 14:36 ET
|
XpandMusic
LOS ANGELES, April 18, 2023 (GLOBE NEWSWIRE) -- The famous quote “Art imitates life” has never been more meaningful to what happens in the feature film “The Midway Point”. Written and directed by...
Researchers Discover a New Embryonic Brain Circuit
April 13, 2023 10:54 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
EMBARGOED UNTIL 17-APR-2023 11:00 ET The findings may provide new insights into circuit abnormalities in autism. ...
Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder (ASD)
April 04, 2023 08:00 ET
|
Axial Therapeutics
-- Children aged 5 to 17 with autism are now eligible to enroll in the clinical trial of AB-2004, a gut targeted, molecular therapeutic -- -- Novel small molecule microbiome approach focused on...